Mitsubishi Ufj Trust & Banking Corp United Therapeutics Corp Transaction History

Mitsubishi Ufj Trust & Banking Corp

  • $43.4 Billion
  • Q3 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 49,426 shares of UTHR stock, worth $18 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
49,426
Previous 52,714 6.24%
Holding current value
$18 Million
Previous $16.8 Million 5.47%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$311.04 - $363.55 $1.02 Million - $1.2 Million
-3,288 Reduced 6.24%
49,426 $17.7 Million
Q2 2024

Aug 08, 2024
BUY
$228.26 - $319.04 $3.86 Million - $5.4 Million
16,920 Added 47.27%
52,714 $16.8 Million
Q1 2024

May 10, 2024
SELL
$210.76 - $249.51 $380,421 - $450,365
-1,805 Reduced 4.8%
35,794 $8.22 Million
Q4 2023

Feb 09, 2024
SELL
$214.88 - $256.94 $93,687 - $112,025
-436 Reduced 1.15%
37,599 $8.27 Million
Q3 2023

Nov 09, 2023
SELL
$211.82 - $248.24 $31,137 - $36,491
-147 Reduced 0.38%
38,035 $8.59 Million
Q2 2023

Aug 08, 2023
BUY
$205.19 - $232.99 $1.66 Million - $1.89 Million
8,104 Added 26.94%
38,182 $8.43 Million
Q1 2023

May 10, 2023
BUY
$212.99 - $276.17 $6.2 Million - $8.04 Million
29,101 Added 2978.61%
30,078 $6.74 Million
Q4 2022

Feb 10, 2023
SELL
$205.95 - $280.43 $115,949 - $157,882
-563 Reduced 36.56%
977 $271,000
Q3 2022

Nov 10, 2022
SELL
$203.3 - $244.17 $348,456 - $418,507
-1,714 Reduced 52.67%
1,540 $322,000
Q2 2022

Aug 09, 2022
SELL
$174.81 - $241.14 $237,217 - $327,226
-1,357 Reduced 29.43%
3,254 $767,000
Q1 2022

May 12, 2022
SELL
$166.16 - $213.96 $264,028 - $339,982
-1,589 Reduced 25.63%
4,611 $827,000
Q4 2021

Feb 09, 2022
SELL
$184.32 - $216.08 $90,685 - $106,311
-492 Reduced 7.35%
6,200 $1.34 Million
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $179,860 - $214,880
-1,000 Reduced 13.0%
6,692 $1.24 Million
Q2 2021

Aug 12, 2021
SELL
$170.47 - $211.93 $20,626 - $25,643
-121 Reduced 1.55%
7,692 $1.36 Million
Q1 2021

May 12, 2021
BUY
$153.94 - $174.85 $109,759 - $124,668
713 Added 10.04%
7,813 $1.19 Million
Q4 2020

Feb 12, 2021
SELL
$101.87 - $151.79 $560,285 - $834,845
-5,500 Reduced 43.65%
7,100 $1.08 Million
Q3 2020

Nov 12, 2020
SELL
$99.9 - $121.13 $259,740 - $314,938
-2,600 Reduced 17.11%
12,600 $1.27 Million
Q2 2020

Sep 11, 2020
SELL
$92.74 - $125.82 $787,826 - $1.07 Million
-8,495 Reduced 35.85%
15,200 $1.84 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $991,854 - $1.35 Million
10,695 Added 82.27%
23,695 $1.84 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $689,128 - $838,992
8,800 Added 209.52%
13,000 $1.15 Million
Q3 2019

Nov 12, 2019
BUY
$74.85 - $85.99 $314,370 - $361,158
4,200 New
4,200 $335,000
Q2 2019

Aug 07, 2019
SELL
$76.06 - $120.81 $2.98 Million - $4.74 Million
-39,235 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$107.15 - $126.84 $595,325 - $704,723
5,556 Added 16.5%
39,235 $4.6 Million
Q4 2018

Feb 12, 2019
BUY
$101.4 - $128.73 $140,337 - $178,162
1,384 Added 4.29%
33,679 $3.67 Million
Q3 2018

Nov 13, 2018
SELL
$113.81 - $129.46 $6.94 Million - $7.9 Million
-61,001 Reduced 65.38%
32,295 $4.13 Million
Q2 2018

Aug 10, 2018
BUY
$101.14 - $118.31 $55,627 - $65,070
550 Added 0.59%
93,296 $10.6 Million
Q1 2018

May 11, 2018
SELL
$107.21 - $151.94 $40,847 - $57,889
-381 Reduced 0.41%
92,746 $10.4 Million
Q4 2017

Feb 09, 2018
BUY
$118.58 - $151.28 $560,646 - $715,251
4,728 Added 5.35%
93,127 $13.8 Million
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $10.1 Million - $12.1 Million
88,399
88,399 $10.4 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email